Richard Bulbulia, MA, MD, FRCS
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Wednesday, November 15, 2023 |
Presenter
New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimibe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For: The CLEAR RCT Show That Bempedoic Acid Really Works
7:28 AM - 7:33 AM
|
Friday, November 17, 2023 |
Presenter
DEBATE: Update On ACST 2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates And Implied That Both Invasive Treatments Were Superior To BMT: Does CEA Prevent Dementia
1:06 PM - 1:11 PM
|
Presenter
Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimide, (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol)
3:12 PM - 3:17 PM
|
previous | next |